Sökning: id:"swepub:oai:DiVA.org:umu-126327" >
Pre-diagnostic seru...
Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants : a nested case-control study
-
- Späth, Florentin (författare)
- Umeå universitet,Onkologi
-
- Andersson, Ulrika (författare)
- Umeå universitet,Onkologi
-
- Dahlin, Anna M. (författare)
- Umeå universitet,Onkologi,Computational Life Science Cluster (CLiC), Umeå University, 901 87 Umeå, Sweden
-
visa fler...
-
Langseth, Hilde (författare)
-
Hovig, Eivind (författare)
-
Johannesen, Tom Borge (författare)
-
- Grankvist, Kjell (författare)
- Umeå universitet,Klinisk kemi
-
- Björkblom, Benny (författare)
- Umeå universitet,Kemiska institutionen
-
- Wibom, Carl (författare)
- Umeå universitet,Onkologi,Computational Life Science Cluster (CLiC), Umeå University, 901 87 Umeå, Sweden
-
- Melin, Beatrice (författare)
- Umeå universitet,Onkologi
-
visa färre...
-
(creator_code:org_t)
- 2016-02-23
- 2016
- Engelska.
-
Ingår i: Tumor Biology. - : Springer Science and Business Media LLC. - 1010-4283 .- 1423-0380. ; 37:8, s. 11065-11072
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://umu.diva-por... (primary) (Raw object)
-
https://link.springe...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Genetic variants have been associated with the risk of developing glioma, but functional mechanisms on disease phenotypic traits remain to be investigated. One phenotypic trait of glioblastoma is the mutation and amplification of the epidermal growth factor receptor (EGFR) gene. We investigated associations between pre-diagnostic serum protein concentrations of EGFR and ErbB2, both members of the EGFR family, and future risk of glioma. Further, we studied if EGFR glioma risk variants were associated with EGFR and ErbB2 serum levels. We assessed the associations between genetic glioma risk variants and serum concentrations of EGFR and ErbB2, as measured in pre-diagnostic cohort serum samples of 593 glioma patients and 590 matched cancer-free controls. High serum EGFR and ErbB2 levels were associated with risk of developing glioblastoma (P = 0.008; OR = 1.58, 95 % CI = 1.13-2.22 and P = 0.017, OR = 1.63, 95 % CI = 1.09-2.44, respectively). High serum ErbB2 concentration was also associated with glioma risk overall (P = 0.049; OR = 1.39, 95 % CI = 1.00-1.93). Glioma risk variants were not associated with high serum protein abundance. In contrast, the EGFR risk variant rs4947986 (T) was correlated with decreased EGFR serum levels (study cohort P = 0.024 and controls P = 0.009). To our knowledge, this is the first study showing an association of EGFR and ErbB2 serum levels with glioma more than a decade before diagnosis, indicating that EGFR and ErbB2 serum proteins are important in early gliomagenesis. However, we did not find evidence that glioma risk variants were associated with high pre-diagnostic serum concentrations of EGFR and ErbB2.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- Glioma
- SNP
- Serum EGFR
- Serum ErbB2
- Pre-diagnostic
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Späth, Florentin
-
Andersson, Ulrik ...
-
Dahlin, Anna M.
-
Langseth, Hilde
-
Hovig, Eivind
-
Johannesen, Tom ...
-
visa fler...
-
Grankvist, Kjell
-
Björkblom, Benny
-
Wibom, Carl
-
Melin, Beatrice
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Tumor Biology
- Av lärosätet
-
Umeå universitet